psychoses
Conditions
Interventions
test:Oral 2mg the test tablets
reference:Oral 2mg the control tablets
Sponsors
First Affiliated Hospital, College of Medicine, Zhejiang University
Eligibility
Sex/Gender
Male
Age
19 Years to 27 Years
Inclusion criteria
Inclusion criteria: (1) Male,Aged from 18 to 40 years old, no more than 10 years in age difference of thee subjects in the same group; (2) BMI ranged from 19 to 25 kg/m2; (3) No history of organic disease and drugallergy; (4) Subjects with normal findings as determined by baseline history, physical examination, vital signs, Haemogram with ESR, Biochemistry, Infectious Disease Screening (HIV,Hepatitis B and Hepatitis C) and Urinalysis, ECG; (5) No drug abuser; (6) No alcoholic and smoking addiction; (7) Good communication with researchers and complied for requirements during the whole research work; (8) given a written informed- consent form and sign on the ICF.
Exclusion criteria
Exclusion criteria: (1) Participated in other clinical research within 3 months; (2) Had a history of blood donation within 1 month or intended to donate blood during the trial; (3) Failed in the general examination, blood pressure, heart rate and breath condition; (4) Any obvious clinical symptoms of disease founded during the medical examination; (5) laboratory evidence of hematology renal cardiac and hepatic abnormity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The plasma concentrations of RIS; | — |
Secondary
| Measure | Time frame |
|---|---|
| The plasma concentrations of 9-OH RIS; | — |
Countries
China
Contacts
Public ContactJianzhong Shen-Tu
First Affiliated Hospital, College of Medicine, Zhejiang University
Outcome results
None listed